Cell-derived composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9464272
SERIAL NO

14567457

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is directed to a cell-derived composition having bone growth, regeneration, and repair promoting properties. In particular, the invention is directed to a cell-derived composition having bone growth, regeneration, and repair promoting properties termed Amnion-derived Cellular Cytokine Solution-B (ACCS-B). The invention is further directed to the use of this composition to promote bone growth and/or regeneration and/or repair.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STEMNION INC100 TECHNOLOGY DRIVE SUITE 200 PITTSBURGH PA 15219

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fried, Christopher A Pittsburgh, US 2 5
Meyn,, III Malcolm A Pittsburgh, US 3 5
Olejniczak, Donna M Pittsburgh, US 4 5
Rupp, Randall G Swanton, US 25 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00